STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort

Camidge

Hellmann

Gibney

Samstein

Skoulidis

Biton

Aggarwal

Facchinetti

Pécuchet

Shackelford

Koyama

Arbour

Frank

Krall, 2017, Keap1 loss modulates sensitivity to kinase targeted therapy in lung cancer, Elife, 6

Kansanen

Singal

Gu

Mayakonda

Griffith, 2019, Characterizing the feasibility and performance of real-world tumor progression end points and their association with overall survival in a large advanced Non–Small-Cell lung cancer data set, JCO Clin Cancer Inform, 3, 1, 10.1200/CCI.19.00013

Curtis